However, recent studies have indicated that SIRT1 is a crucial regulator of fibroblast activation in systemic sclerosis (SSc), and TGF-β signaling and collagen expression can be effectively inhibited by the knockdown of SIRT1 (Zerr et al., 2016). Here, SIRT1 is linked to systemic sclerosis.